Efficacy of cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study.

Sandrine A UrwylerIrene SamperiKirstie LithgowAkash MavilakandyMike MatheouKarin BradleyAparna PalNarendra L ReddyJohn AyNiki Karavitaki

Published in: European journal of endocrinology (2024)

In non-irradiated patients, cabergoline normalises IGF-1 in around one-third and achieves both IGF-1 and GH targets in approximately one out of ten cases. SRL+cabergoline is less efficient than previously reported possibly due to differences in studies methodology and impact of confounding factors.

Keyphrases

growth hormone
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors
binding protein
pi k akt
patient reported outcomes
cell proliferation